NIDAN

NIDAN LABORATORIES AND HEALTHCARE

Small Cap NSE: NIDAN
₹52.2
-1.8 (-3.33%)
As on 07 December, 2022 | 15:36

Nidan Laboratories And Healthcare Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in NIDAN LABORATORIES AND HEALTHCARE

Start SIP

Nidan Laboratories And Healthcare Share Price

Nidan Laboratories And Healthcare Share Returns

  • Over 1 Month -2.43%
  • Over 3 Month -21.33%
  • Over 6 Month 37.73%
  • Over 1 Year -16.88%

Nidan Laboratories And Healthcare Key Statistics

P/E Ratio
PEG Ratio
Market Cap Cr 73
Price to Book Ratio 1.1
EPS 1.8
Dividend 0
Relative Strength Index 48.76
Money Flow Index 80.4
MACD Signal -0.43
Average True Range 2.04

Nidan Laboratories And Healthcare Investment Rating

  • Master Rating:
  • Nidan Laboratories And Healthcare has an operating revenue of Rs. 93.24 Cr. on a trailing 12-month basis. An annual revenue growth of 40% is outstanding, Pre-tax margin of 15% is great, ROE of 4% is fair but needs improvement. The company has a reasonable debt to equity of 14%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 21% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 49 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 93 indicates it belongs to a poor industry group of Medical-Services and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

N/A

Price Strength

Buyer Demand

Group Rank

Nidan Laboratories And Healthcare Financials
Indicator
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr

Nidan Laboratories And Healthcare Technicals

EMA & SMA

Current Price
52.2
-1.8 (-3.33%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 54.15
  • 50 Day
  • 53.9
  • 100 Day
  • 51.42
  • 200 Day
  • 50.54
  • 20 Day
  • 54.22
  • 50 Day
  • 55.59
  • 100 Day
  • 49.75
  • 200 Day
  • 44.36

Nidan Laboratories And Healthcare Resistance and Support

PIVOT
₹54.12
Resistance
First Resistance 54.24
Second Resistance 54.47
Third Resistance 54.59
RSI 48.76
MFI 80.41
MACD Single Line -0.43
MACD -0.35
Support
First Resistance 53.89
Second Resistance 53.77
Third Resistance 53.54

Nidan Laboratories And Healthcare Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 3,000 300,000 100
Week 7,000 640,010 91.43
1 Month 8,857 723,806 81.72
6 Month 25,488 2,027,316 79.54

Nidan Laboratories And Healthcare Result Highlights

Nidan Laboratories And Healthcare Synopsis

NSE-Medical-Services

Nidan Laboratories is involved in the business activities of Other Hospital and Medical Care Activities. Company’s Total Operating Revenue is Rs. 29.66 Cr. and Equity Capital is Rs. 13.90 Cr. for the Year ended 31/03/2022. Nidan Laboratories And Healthcare Ltd. is a Public Limited Listed company incorporated on 05/12/2000 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is U33111MH2000PLC129883 and registration number is 129883.
Market Cap 73
Sales 30
Shares in Float 0.40
No of funds
Yield
Book Value 1.14
U/D Vol ratio 1.1
LTDebt / Equity 14
Alpha
Beta 1.1

Nidan Laboratories And Healthcare

Owner NameSep-22Mar-22
Promoters 71.22%71.22%
Others 28.78%28.78%

Nidan Laboratories And Healthcare Management

Name Designation
Mr. Edwin Francis Dabre Executive Director
Mrs. Tejal Anil Jayakar Executive Director & CFO
Mr. Krupesh Deepak Thakur Non Executive Director
Mr. Nilesh Ghanshyam Bide Ind. Non-Executive Director
Mr. Abhinay Shashikant Nerurkar Ind. Non-Executive Director
Mr. Karim Hakam Khimani Ind. Non-Executive Director

Nidan Laboratories And Healthcare Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Nidan Laboratories And Healthcare Corporate Action

Date Purpose Remarks
2022-11-11 Quarterly Results

Nidan Laboratories And Healthcare FAQs

What is Share Price of Nidan Laboratories And Healthcare ?

Nidan Laboratories And Healthcare share price is ₹52 As on 07 December, 2022 | 15:22

What is the Market Cap of Nidan Laboratories And Healthcare ?

The Market Cap of Nidan Laboratories And Healthcare is ₹72.6 Cr As on 07 December, 2022 | 15:22

What is the P/E ratio of Nidan Laboratories And Healthcare ?

The P/E ratio of Nidan Laboratories And Healthcare is As on 07 December, 2022 | 15:22

What is the PB ratio of Nidan Laboratories And Healthcare ?

The PB ratio of Nidan Laboratories And Healthcare is 1.1 As on 07 December, 2022 | 15:22

Q2FY23